Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See
full details
.
I Agree
×
Join today and have your say! It’s FREE!
Join Now
Sign In
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.
Join Today
or
Sign in with existing account
Privacy Policy
|
Disclaimer
Sign In
Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Remember me
Forgot Password?
Sign In
or
Sign Up
Privacy Policy
|
Disclaimer
Please Try Again
{{ error }}
Send my password
Submit
Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Linking with Facebook:
Stockhouse membership requires an email address which must be shared by Facebook.
By default, joining or signing in using your Facebook account will work and the email address will be shared by Facebook automatically.
If you change your Facebook permissions to restrict Stockhouse from receiving your email while joining or signing in to Stockhouse then it will fail.
Please do not modify the permission settings during sign-in.
Sign in with Facebook
Return to Signup Options
Home
Community
Bullboards
Blogs
Groups
Messages
Markets
Stocks
TSX
TSXV
CSE
Cboe Canada
NASDAQ
NYSE
NYSE American
Cryptocurrency
Currencies
Market Movers
Bonds
News
Featured News
Trending News
Canadian Press Releases
US Press Releases
Video
Editorial
Thematic Insights
Independent Reports
Interviews
Buzz on the Bullboards
Portfolio
Watchlist
Portfolio
Showcase Companies
DealRoom
News Focus
Northstar Gold Signs MOU with Hunan Nonferrous Ltd. to Develop Gold Resource (click to learn more)
Quote
|
Bullboard
|
News
|
Opinion
|
Profile
|
Peers
|
Filings
|
Financials
|
Options
|
Price History
|
Ratios
|
Ownership
|
Insiders
|
Valuation
Bullboard - Stock Discussion Forum
Oncolytics Biotech Inc
T.ONC
Alternate Symbol(s):
ONCY
Healthcare
Biotechnology
Oncolytics Biotech Inc. is a clinical-stage biotechnology company. The Company is focused on developing pelareorep, an intravenously delivered immunotherapeutic agent that activates the innate and adaptive immune systems and weakens tumor defense mechanisms. This compound induces anti-cancer immune responses and promotes an inflamed tumor phenotype turning cold tumors hot through innate and...
adaptive immune responses to treat a variety of cancers. This improves the ability of the immune system to fight cancer, making tumors more susceptible to a broad range of oncology treatments. The Company’s primary focus is to advance its programs in hormone receptor-positive / human epidermal growth factor 2- negative (HR+/HER2-) metastatic breast cancer and advanced/metastatic pancreatic ductal adenocarcinoma to registration-enabling clinical studies. In addition, it is exploring opportunities for registrational programs in other gastrointestinal cancers through its GOBLET platform study.
see more
Join the community and start posting on the bullboards today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Create a portfolio watchlist today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Add To Watchlist
Bullboard (TSX:ONC)
New Post
View:
Posts & Comments
Threaded Posts
Prev
...
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
...
Next
(235)
•••
itntdf
X
View Profile
View Bullboard History
Comment by
itntdf
on Aug 26, 2024 6:42am
RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:USA Inflation Reduction Act (IRA) 2022 Re: Biotech and China
i'm sorry for your loss. a mind is a terrile thing to misplace. maybe you can find yours. news flash! biden was sworn into office on january 21, 2021 which is when he assumed office -
...more
(527)
•••
Peladawn
X
View Profile
View Bullboard History
Comment by
Peladawn
on Aug 25, 2024 10:08pm
RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:USA Inflation Reduction Act (IRA) 2022 Re: Biotech and China
Propagandist lies are going to destroy this country and it's people like you who spew hatred without even having a clue of what you're talking about that are helping it to happen...you and
...more
Northstar Gold Signs MOU with Hunan Nonferrous Ltd. to Develop Gold Resource
posted Sep 19, 2024 9:00am by
Northstar Gold Corp.
-
|
The MOU grants Hunan Nonferrous the opportunity to explore and develop a near-surface NI43-101 gold mineral resource at Northstar’s 100%-owned Miller Copper-Gold Property, located 18 kilometers southeast of Kirkland Lake, Ontario. This will be achieved by diamond drilling up to 10,000 meters, allowing Hunan Nonferrous to earn a negotiated interest in the resultant NI43-101 gold resource. ...read more
(527)
•••
Peladawn
X
View Profile
View Bullboard History
Comment by
Peladawn
on Aug 25, 2024 10:01pm
RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:USA Inflation Reduction Act (IRA) 2022 Re: Biotech and China
"first, there was nobody with common sense occupying the oval office in 2019. second, your man with "common sense" signed his proclamation to ban entry from china on
...more
(5620)
•••
Noteable
X
View Profile
View Bullboard History
Comment by
Noteable
on Aug 25, 2024 5:14pm
RE:RE:RE:RE:RE:RE:RE:RE:Big pharma is set to keep signing bigger deals in 2024
The end to Biotech’s bear market – and early recovery – explained Portfolio Manager Andy Acker joins a panel discussion during the Accelerating Bio-Innovation 2024 Conference in Cambridge
...more
(5620)
•••
Noteable
X
View Profile
View Bullboard History
Comment by
Noteable
on Aug 25, 2024 5:05pm
RE:RE:RE:RE:RE:RE:RE:Big pharma is set to keep signing bigger deals in 2024
After three years of underperformance, the biotech sector is exhibiting compelling indications of a revitalization, according to Jeffries. The industry is reaching the looming patent cliff
...more
(5620)
•••
Noteable
X
View Profile
View Bullboard History
Comment by
Noteable
on Aug 25, 2024 10:48am
RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:USA Inflation Reduction Act (IRA) 2022 Re: Biotech and China
The US House Select Committee on the Chinese Communist Party, the driving force behind the draft BIOSECURE Act, has set its eyes on the next target in its crackdown against China. Alongside the
...more
(5620)
•••
Noteable
X
View Profile
View Bullboard History
Comment by
Noteable
on Aug 25, 2024 10:35am
RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:USA Inflation Reduction Act (IRA) 2022 Re: Biotech and China
Merck is trying to determine the reasons behind the surprise decline of its HPV vaccine, Gardasil in China. and a preliminary reading is because the CCP continues to influence the Chinese
...more
(5620)
•••
Noteable
X
View Profile
View Bullboard History
Comment by
Noteable
on Aug 24, 2024 8:19pm
RE:RE:RE:RE:RE:RE:PwC sees continuation of US$ 5 to 15 Billion Bio M&A Deals
An increasingly positive opinion is appearing concerning emerging biologics highlighting that with the IRA creating a longer window for price negotiation on large molecule drugs—13 years compared to 9
...more
(75)
•••
Journeytc
X
View Profile
View Bullboard History
Comment by
Journeytc
on Aug 24, 2024 7:51pm
RE:RE:Finally a Phase III trial...
Oops i jumped the gun reading title but not date. My apologies.
(75)
•••
Journeytc
X
View Profile
View Bullboard History
Comment by
Journeytc
on Aug 24, 2024 7:40pm
RE:Finally a Phase III trial...
Great news and just as i predicted and blogged. Take breast cancer trial through the back door. Screw the FDA and Pfizer. They made sure Pela would fail! They didnt want
...more
(91)
•••
venture009
X
View Profile
View Bullboard History
Comment by
venture009
on Aug 24, 2024 6:10pm
RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:USA Inflation Reduction Act (IRA) 2022 Re: Biotech and China
For most of what you are complaining about, you have the benefit of a rear view mirror aspect. The most destructive policies of the whole covid period, which we still haven't recovered from, we
...more
(210)
•••
pelaboost
X
View Profile
View Bullboard History
Post by
pelaboost
on Aug 24, 2024 1:00pm
@itntdf
Very well said. Going forward - Toujours optimiste! Udachi!
(5620)
•••
Noteable
X
View Profile
View Bullboard History
Comment by
Noteable
on Aug 24, 2024 12:29pm
RE:RE:RE:RE:RE:PwC sees continuation of US$ 5 to 15 Billion Bio M&A Deals
August 01, 2024 - " With the IRA creating a longer window for price negotiation on large molecule drugs—13 years compared to 9 years for small molecule drugs—companies also have a
...more
(5620)
•••
Noteable
X
View Profile
View Bullboard History
Comment by
Noteable
on Aug 24, 2024 12:14pm
RE:RE:RE:RE:PwC sees continuation of US$ 5 to 15 Billion Bio M&A Deals
June 2024 - PwC - Germany - M&A will continue to be a critical tool to unlock value and drive innovation across health industries as dealmakers gear up for a busy second half of 2024. "
...more
Prev
...
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
...
Next
Thank You
Your Report has been submitted.
Report Abusive Content
×
Close
Sign up to get access
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
The Market Update
{{currentVideo.title}}
{{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >
A daily snapshot of everything
from market open to close.
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}
{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >
Featured News Links
Mining Player Sells Off Promising Project for Millions – Here's Where the Cash is Headed
EnviroGold Global Announces Appointment of Chief Operating Officer